AtCor Medical is a leader in developing and marketing cardiovascular technologies for risk assessment and patient management.

ATCOR MEDICAL INVESTOR

NEW Broker Coverage
Taylor Collison Sharebrokers and Investment Advisers have initiated coverage of AtCor Medical Holdings Limited.

Please click here to view the report.

Newsletter
Welcome to the first edition of our new investor newsletter. Our objective is to keep you informed of the key initiatives and programs that will drive the growth and progress of your company around the world.

Please click here to view the Investor Newsletter.

 VIEW PRODUCT DEMONSTRATION

The SphygmoCor system provides a quick and non-invasive method of obtaining key cardiovascular data thereby enhancing the treatment and management of patients.

Click below to view a brief demonstration of the steps involved in taking a SphygmoCor measurement. 

Click here for demonstration

 NEWS

7 May 2008 : AtCor Medical Receives Russian Marketing Approval

23 April 2008 : New Study Shows Central Blood Pressure Is Superior

15 April 2008 : AtCor Medical Announces Third Quarter Report - Appendix 4C

10 April 2008 : Investor Presentation

22 February 2008  : AtCor Medical Released Half Year Results